top of page

Latest News

CHANGES TO APPLICATION PROCESS 
Expiring the Experienced Practioner Route 
 

Please take a moment to review the linked PDF memo for more details. We appreciate your support and cooperation as we strive to improve our application process.

Important Public Health Update on GLP-1 RAs

Health Canada Marketed Health Products Directorate has issued the following information regarding a summary safety review for Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RAs) (dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide)

 


 

bottom of page